Overview

Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Extracorporeal Photopheresis with UVADEX (ECP) prior to bone marrow or peripheral blood stem cell transplantation is effective in the prevention of Graft-versus-Host Disease (GvHD).
Phase:
Phase 2
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Methoxsalen